CXCR5
C-X-C chemokine receptor type 5
Also known as: BLR1, CD185, CXCR5_HUMAN, MDR15
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P32302
- Gene
- CXCR5
- Ensembl
- ENSG00000160683
- Chromosome
- 11
- Canonical length
- 372 aa
- Protein class
- CD markers, G-protein coupled receptors, Predicted membrane proteins
OverviewNCBI Gene
This gene encodes a multi-pass membrane protein that belongs to the CXC chemokine receptor family. It is expressed in mature B-cells and Burkitt's lymphoma. This cytokine receptor binds to B-lymphocyte chemoattractant (BLC), and is involved in B-cell migration into B-cell follicles of spleen and Peyer patches. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Aug 2011]
Canonical amino-acid sequenceUniProt
372 residues, UniProt reviewed canonical sequence.
>P32302|CXCR5
1 MNYPLTLEMD LENLEDLFWE LDRLDNYNDT SLVENHLCPA TEGPLMASFK AVFVPVAYSL
61 IFLLGVIGNV LVLVILERHR QTRSSTETFL FHLAVADLLL VFILPFAVAE GSVGWVLGTF
121 LCKTVIALHK VNFYCSSLLL ACIAVDRYLA IVHAVHAYRH RRLLSIHITC GTIWLVGFLL
181 ALPEILFAKV SQGHHNNSLP RCTFSQENQA ETHAWFTSRF LYHVAGFLLP MLVMGWCYVG
241 VVHRLRQAQR RPQRQKAVRV AILVTSIFFL CWSPYHIVIF LDTLARLKAV DNTCKLNGSL
301 PVAITMCEFL GLAHCCLNPM LYTFAGVKFR SDLSRLLTKL GCTGPASLCQ LFPSWRRSSL
361 SESENATSLT TFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CXCR5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 29 nTPM
Expression across tissuesHPA
Tissue
- lymph node: 29 nTPM
- spleen: 24 nTPM
- tonsil: 15 nTPM
- small intestine: 13 nTPM
- appendix: 11 nTPM
- bone marrow: 8.9 nTPM
Single-cell type
- b-cells: 109 nCPM
- epicardial cells: 71 nCPM
- cardiomyocytes: 45 nCPM
- innate lymphoid cells: 14 nCPM
- vascular smooth muscle cells: 7.8 nCPM
- medullary thymic epithelial cells: 7.2 nCPM
Immune cell
- naive B-cell: 93 nTPM
- memory B-cell: 68 nTPM
- memory CD4 T-cell: 11 nTPM
- total PBMC: 6.2 nTPM
- memory CD8 T-cell: 3 nTPM
- T-reg: 1.7 nTPM
Brain region
- cerebellum: 0.3 nTPM
- cerebral cortex: 0.2 nTPM
- basal ganglia: 0.1 nTPM
- hypothalamus: 0.1 nTPM
- medulla oblongata: 0.1 nTPM
- amygdala: 0 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.55
- gnomAD pLI
- 0.73
- gnomAD missense Z
- 2.15
- DepMap mean gene effect
- 0.12
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- B cell activation
- calcium-mediated signaling
- cell chemotaxis
- G protein-coupled receptor signaling pathway
- immune response
- leukocyte chemotaxis
- lymph node development
- positive regulation of cytokinesis
- positive regulation of cytosolic calcium ion concentration
Molecular functions
- C-C chemokine binding
- C-C chemokine receptor activity
- C-X-C chemokine receptor activity
- G protein-coupled receptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CXCR5 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CXCR5 as an antibody target. Whether an autoantibody or antibody against CXCR5 could matter depends on whether native CXCR5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CXCR5 is annotated at the cell surface, where native CXCR5 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CXCR5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...